Seguir
Felipe von Glehn MD, PhD, FAAN
Felipe von Glehn MD, PhD, FAAN
E-mail confirmado em unb.br
Título
Citado por
Citado por
Ano
Alterations of the human gut microbiome in multiple sclerosis
S Jangi, R Gandhi, LM Cox, N Li, F Von Glehn, R Yan, B Patel, ...
Nature communications 7 (1), 1-11, 2016
8232016
Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse
ALF Longhini, F von Glehn, CO Brandão, RFO de Paula, F Pradella, ...
Journal of neuroinflammation 8 (1), 1-4, 2011
662011
Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients
F von Glehn, AS Farias, ACP de Oliveira, A Damasceno, ALF Longhini, ...
Multiple Sclerosis Journal 18 (7), 1038-1041, 2012
652012
Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis
R Raheja, K Regev, BC Healy, MA Mazzola, V Beynon, F Von Glehn, ...
Muscle & nerve 58 (2), 261-269, 2018
632018
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders
F von Glehn, S Jarius, RP Cavalcanti Lira, MC Alves Ferreira, ...
Multiple Sclerosis Journal 20 (9), 1189-1197, 2014
622014
Association between serum MicroRNAs and magnetic resonance imaging measures of multiple sclerosis severity
K Regev, BC Healy, F Khalid, A Paul, R Chu, S Tauhid, S Tummala, ...
JAMA neurology 74 (3), 275-285, 2017
552017
Prognostic indicators for long-term disability in multiple sclerosis patients
A Damasceno, F Von Glehn, CO Brandão, BP Damasceno, F Cendes
Journal of the neurological sciences 324 (1-2), 29-33, 2013
542013
Impact of electroacupuncture on quality of lifefor patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study
JG Quispe-Cabanillas, A Damasceno, F von Glehn, CO Brandão, ...
BMC complementary and alternative medicine 12 (1), 1-7, 2012
412012
Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of …
DG Brum, ER Comini-Frota, CCF Vasconcelos, E Dias-Tosta
Arquivos de Neuro-Psiquiatria 72, 152-156, 2014
272014
Knee flexor strength and balance control impairment may explain declines during prolonged walking in women with mild multiple sclerosis
C Ramari, AG Moraes, CB Tauil, F von Glehn, R Motl, AC de David
Multiple sclerosis and related disorders 20, 181-185, 2018
262018
Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7: 12015
S Jangi, R Gandhi, LM Cox, N Li, F Von Glehn, R Yan, B Patel, ...
262016
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis
F Von Glehn, LM Santos, KE Balashov
Immunotherapy 4 (10), 1053-1061, 2012
252012
Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016; 7: 12015
S Jangi, R Gandhi, LM Cox, N Li, F Von Glehn, R Yan, B Patel, ...
Epub 2016/06/29. https://doi. org/10.1038/ncomms12015 PMID: 27352007, 0
24
The suppressive effect of IL‐27 on encephalitogenic Th17 cells induced by multiwalled carbon nanotubes reduces the severity of experimental autoimmune encephalomyelitis
AS Moraes, RFO Paula, F Pradella, MPA Santos, EC Oliveira, ...
CNS neuroscience & therapeutics 19 (9), 682-687, 2013
232013
Monthly variation of multiple sclerosis activity in the southern hemisphere: analysis from 996 relapses in Brazil
A Damasceno, F Von Glehn, L de Deus‐Silva, BP Damasceno
European Journal of Neurology 19 (4), 660-662, 2012
212012
Dimethyl fumarate downregulates the immune response through the HCA2/GPR109A pathway: implications for the treatment of multiple sclerosis
F von Glehn, RPC Dias-Carneiro, AS Moraes, AS Farias, VAPG Silva, ...
Multiple sclerosis and related disorders 23, 46-50, 2018
192018
Cerebrospinal fluid analysis in the context of CNS demyelinating diseases
SLA Matas, F Glehn, GBP Fernandes, CAS Soares
Arquivos de neuro-psiquiatria 71, 685-688, 2013
172013
Th17 cells: A prognostic marker for MS rebound after natalizumab cessation?
J Haas, K Schneider, A Schwarz, M Korporal-Kuhnke, S Faller, ...
Multiple Sclerosis Journal 23 (1), 114-118, 2017
162017
Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis
AG Moraes, SGR Neri, RW Motl, CB Tauil, F von Glehn, ÉC Corrêa, ...
Multiple sclerosis and related disorders 43, 102203, 2020
152020
Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells
MA Mazzola, R Raheja, K Regev, V Beynon, F von Glehn, A Paul, I Pierre, ...
Multiple Sclerosis Journal 25 (1), 63-71, 2019
152019
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20